- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04915911
Nutritional Status and Body Composition of Adult Patients With Crohn's Disease
July 14, 2021 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
A Multi-center, Cross-sectional Observational Study on Nutritional Status and Body Composition of Adult Patients With Crohn's Disease
Patients with Crohn's disease generally have nutritional risks and malnutrition.
The investigators will conduct a multicenter cross-sectional study to discover nutritional status and body composition of Chinese adult patients with CD.
Study Overview
Detailed Description
Several studies have found that the body composition of CD patients is related to disease and therapies.
Due to lack of a prospective multicenter cross-sectional observational study on the nutritional status and body composition of adult patients with CD in China.
Evaluating the nutritional status and body composition of these patients can help formulate individualized nutritional support strategies for adult CD patients.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pianhong Zhang, MS
- Phone Number: +86 8778 3852
- Email: zrlcyyzx@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310009
- Recruiting
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University
-
Contact:
- Pianhong Zhang, Ms
- Phone Number: +86 87783852
- Email: zrlcyyzx@zju.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Chinese adult patients with Crohn's Disease
Description
Inclusion Criteria:
- Age ≥ 18 years old;
- diagnosis of CD;
- Admission time <48 hours;
- Subject has voluntarily signed and dated an informed consent form.
Exclusion Criteria:
- Emergency surgery for intestinal fistula or abdominal abscess;
- Unstable vital signs or unstable hemodynamics;
- Pregnant or lactating women;
- Admission to hospital due to other critical illnesses (such as tumor, HIV, severe infections requiring ventilator or CRRT treatment);
- Dying patients whose life expectancy does not exceed 24 hours;
- Severe liver insufficiency (liver function score 11-15 or total bilirubin> 3mg/dL or tissue biopsy diagnosed as liver cirrhosis, hepatic encephalopathy, portal hypertension with history of gastrointestinal hemorrhage, etc.);
- Severe renal insufficiency (creatinine value is 2 times higher than the upper limit of normal);
- Severe metabolic diseases (such as metabolic syndrome, hyperthyroidism, etc.);
- Patients whose burn area exceeds 20% of the body surface area;
- Immunodeficiency, autoimmune disease, or receiving immunosuppressive treatment for diseases other than CD (such as organ transplantation, etc.);
- Those who are not suitable for body composition analysis
- Patients who have been selected for other clinical studies or have been selected for this study;
- Subjects are unwilling to participate in this study or refuse to sign informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
adult patients with Crohn's disease
multi-center cross-sectional study
|
cross-sectional study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appendicular skeletal mass index
Time Frame: Within 48 hours of admission to hospital
|
Bioelectrical impedance analysis
|
Within 48 hours of admission to hospital
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: Within 48 hours of admission to hospital
|
Especially body fat mass by bioelectrical impedance analysis
|
Within 48 hours of admission to hospital
|
|
Nutritional risk screening
Time Frame: Within 48 hours of admission to hospital
|
Detect the presence of undernutrition and the risk of developing undernutrition by Risk Screening 2002 (NRS-2002), when score≥3, the patient is nutritionally at-risk
|
Within 48 hours of admission to hospital
|
|
Nutritional assessment
Time Frame: Within 48 hours of admission to hospital
|
Detect malnourished individuals by the Subjective Global Assessment (SGA) , where A is well nourished and C is severely malnourished
|
Within 48 hours of admission to hospital
|
|
Grip strength
Time Frame: Within 48 hours of admission to hospital
|
Hand grip strength test
|
Within 48 hours of admission to hospital
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Anticipated)
May 1, 2023
Study Completion (Anticipated)
May 1, 2023
Study Registration Dates
First Submitted
April 11, 2021
First Submitted That Met QC Criteria
May 31, 2021
First Posted (Actual)
June 7, 2021
Study Record Updates
Last Update Posted (Actual)
July 15, 2021
Last Update Submitted That Met QC Criteria
July 14, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-1109
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Crohn Disease
-
Turku University HospitalUniversity of TurkuRecruitingInflammatory Bowel Diseases | Crohn Disease | Crohn Colitis | Crohn's Ileocolitis | Crohn Disease in Remission | Crohn Disease of Small IntestineFinland
-
Tzaneio General HospitalRecruitingCrohn Disease (CD) | Crohn Disease of Ileum | Kono S Anastomosis | Extended Mesenteric ExcisionGreece
-
L2 Bio, LLCFDAMap; Akan Biosciences, Inc.Not yet recruitingCrohn&Amp;#39;s | Crohn&Amp;#39;s Disease (CD)
-
University Hospital, Clermont-FerrandNot yet recruiting
-
Central Hospital, Nancy, FranceNot yet recruitingCrohn Disease (CD)France
-
GLSMED Learning Health S.A.Not yet recruiting
-
University Hospital, Clermont-FerrandActive, not recruiting
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Direct Biologics, LLCNot yet recruiting
-
University Hospital, GrenobleNot yet recruiting
Clinical Trials on cross-sectional study
-
Istanbul University - Cerrahpasa (IUC)CompletedFall | Vertebral Fracture | Postmenopausal Osteoporosis | Fracture of VertebraTurkey
-
Singapore National Eye CentreSingHealth Translational Immunology and Inflammation Centre; TTSH Eye ClinicCompletedDry Eye Syndrome | AutoimmunitySingapore
-
Singapore National Eye CentreSingapore General HospitalCompletedDry Eye | GVHDSingapore
-
University of CopenhagenRecruiting
-
Hossam Adly MohamedRecruitingPeripheral Vascular Diseases and Presentation in Patient With Autoimmune DiseasesEgypt
-
Philipps University MarburgCompletedDepression | Anxiety | Body Dysmorphic DisordersGermany
-
Centre de Recherche Médicale et SanitaireCompletedto Contribute to a Better Control of COVID-19 in Children in NigerNiger
-
CalydialCompletedHemodialysis | DIALYSIS SYMPTOMS AND ANXIETYFrance
-
University Hospital, GhentUniversity GhentCompletedOverweight and ObesityBelgium
-
Medical University of GrazRecruitingCovid19 | Stress | Bipolar DisorderAustria